Related references
Note: Only part of the references are listed.Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthma
Jordi Roca-Ferrer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway
Carlos Ramos et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Prostaglandin E2's New Trick Decider of Differential Alveolar Cell Life and Death
Jeffrey C. Horowitz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Diminished Prostaglandin E2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary Fibrosis
Toby M. Maher et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Microarray detection of gene overexpression in primary spontaneous pneumothorax
Hsin-Yuan Fang et al.
EXPERIMENTAL LUNG RESEARCH (2010)
Targeting the TGF-beta 1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
Mitchell S. Anscher
ONCOLOGIST (2010)
Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways
Steven K. Huang et al.
FASEB JOURNAL (2009)
Regulation of Transforming Growth Factor-β-dependent Cyclooxygenase-2 Expression in Fibroblasts
Takayoshi Matsumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis
William R. Coward et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: Autocrine mechanisms in myofibroblasts and macrophages
Bruce D. Uhal et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders
Elisa Lappi-Blanco et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) -: art. no. 56
H Kasai et al.
RESPIRATORY RESEARCH (2005)
Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E2 production
RJ Hodges et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Prostaglandin E-2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation
JE Kolodsick et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis
JC Bonner et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression
C Ramos et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice
CB Keerthisingam et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Share Paper
